Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection.|https://dx.doi.org/10.1128/msphere.00706-24
[Clostridioides difficile infections: Update and therapeutic guidelines].|https://dx.doi.org/10.1684/pnv.2024.1181
Internet Parent-Child Interaction Therapy for Maternal Guilt in a Child Abuse Case: A Single Case Study.|https://dx.doi.org/10.7759/cureus.70904
Systematic review of the orally administered microbiome therapeutic, fecal microbiota spores, live-brpk, to prevent recurrence of Clostridioides difficile infection in adults.|https://dx.doi.org/10.1177/20503121241274192
Cerebral salt wasting syndrome in a child with central diabetes insipidus following surgery for recurrent craniopharyngioma: A case report.|https://dx.doi.org/10.1177/2050313X241275445
Microbiota restoration for recurrent Clostridioides difficile infection.|https://dx.doi.org/10.23736/S0031-0808.24.05111-5
Fecal microbiota transplantation through colonoscopy in the treatment of recurrent Clostridioides difficile: Experience at a university center.|https://dx.doi.org/10.1016/j.rgmxen.2024.03.004
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey.|https://dx.doi.org/10.1111/apt.18330
Risk of rehospitalization due to Clostridioides difficile infection among hospitalized patients with Clostridioides difficile: a cohort study.|https://dx.doi.org/10.1017/ice.2024.155
Comparing rates of recurrent infection for first occurrence of Clostridioides difficile between tapered oral vancomycin and standard vancomycin: a retrospective, propensity matched cohort study.|https://dx.doi.org/10.1017/ice.2024.117
Successful Use of Fecal Microbiota Transplantation in Management of Nonobstructive Recurrent Cholangitis Following Total Pancreatectomy and Islet Autotransplant.|https://dx.doi.org/10.14309/crj.0000000000001527
Fecal microbiota transplantation in a patient with chronic diarrhea and primary and secondary immunodeficiency (common variable immunodeficiency and splenectomy).|https://dx.doi.org/10.3389/fcimb.2024.1456672
Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience.|https://dx.doi.org/10.1111/imj.16545
Multicenter study on Clostridioides difficile infections in Mexico: exploring the landscape.|https://dx.doi.org/10.1017/ice.2024.153
Gonococcal infections and risk factors for reinfection: a descriptive and case-case analysis of notifications in the Australian Capital Territory, 2017-2022.|https://dx.doi.org/10.33321/cdi.2024.48.51
Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study.|https://dx.doi.org/10.1093/ofid/ofae570
Improved health-related quality of life in patients with recurrent Clostridioides difficile infection after treatment with faecal microbiota transplantation.|https://dx.doi.org/10.1080/23744235.2024.2415694
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infections in a Cystic Fibrosis Child Previously Screen Positive, Inconclusive Diagnosis (CFSPID): A Case Report.|https://dx.doi.org/10.3390/microorganisms12102059
